 |
|
|
|
|
 |
 |
In anticipation of the upcoming Medica fair in Duesseldorf (November 16-19, 2005), we would like to invite you to meet with us to discuss current projects and the many prospects for the future. The DIARECT management will be attending Medica Wednesday and Thursday (16 & 17/11/05) all day, and we are looking forward to seeing you there. To arrange an appointment, please, give us a call or send an email.
Pleasant reading!
Your DIARECT team
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |
DIARECT Quality and Lot-to-Lot Reproducibility |
 |
 |
 |
Exactly seven years ago DIARECT was founded and during this time we have grown to be a world-wide supplier of recombinant auto-antigens. The high quality of our biotech products have been a guarantee for the development of superb diagnostic products. Most intriguing features of our recombinants are the sophisticated expression and purification systems, the large lot sizes we can achieve, combined with extremely high lot-to-lot consistency. Here is just one example considering tissue-type transglutaminase (produced via recombinant baculovirus).
|
 |
| Open a larger version of this diagram (72 kb) in a new window |
|
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |
DIARECT Quality and State-of-the-Art Technologies |
 |
 |
 |
The high quality of our antigens also fulfils every requirement for emerging multianalyte technologies. The antigens are suitable for chemical coupling using virtually any chemistry and can be spotted to many surfaces. DIARECT's antigens have been used for development and production of array or bead-type multiplex assays ever since their use in these early publications about autoantigen arrays for autoantibody analysis:
- Robinson WH et al., Autoantigen microarrays for multiplex characterization of autoantibody responses, Nature Medicine vol. 8 p. 295-301 (2002);
- A very interesting review: Hueber W et al., Autoantibody profiling for the study and treatment of autoimmune disease, Arthritis Research vol. 4 p.290-295 (2002).
As a perspective how microarray techniques will complement genomic and proteomic approaches for discoveries about autoimmunity this recent publication will be of interest for you:
- Fathman CG et al, An array of possibilities for the study of autoimmunity, Nature vol. 435 p. 605-611 (2005).
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |
SurModics BSA-free biomolecule stabilizer |
 |
 |
 |
 |
| Read more about STABILZYMEŽ NOBLE STABILIZER SZ04 Product Sheet 2005 |
|
DIARECT would also like to inform you of the newest development in SurModics' assay stabilization components. The brand-new formulation, StabilZymeŽ NOBLE, is a BSA-free biomolecule stabilizer, designed to be used for conjugated as well as unmodified proteins and antibody-coated particles in solution. Contact us for the complete line of Surmodics stabilizers.
|
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|